Deutsche Bank analyst Pito Chickering lowered the firm’s price target on Aveanna to $1.70 from $3 and keeps a Buy rating on the shares. The company posted solid Q4 numbers but management lowered the 2023 EBITDA outlook from the mid $140less than range to at least $130M, the analyst tells investors in a research note.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on AVAH:
- Aveanna sees FY23 revenue at least $1.84B, consensus $1.84B
- Aveanna reports Q4 adjusted EPS (3c), consensus (2c)
- Aveanna Healthcare Holdings Announces Fourth Quarter and Full Year 2022 Financial Results
- Aveanna Announces Fourth Quarter and Full Year 2022 Earnings Release Date and Conference Call
- Aveanna downgraded to Underperform from Neutral at Credit Suisse
